Derek Carlson
Child & Adolescent Psychiatry · Green Bay, WINPI 1790775450
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $38,608 of the $54,447 with a category attached, or 70.9%. 20 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 59.6% of the total. Reporting peaked in 2019 at $25,773 and has fallen 99.1% since, to $227 in 2025. Among child & adolescent psychiatry clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $175.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$32K
- Supernus Pharmaceuticals, Inc.$13K
- Corium, LLC$8K
- Lundbeck LLC$154
- Sunovion Pharmaceuticals Inc.$116
- AbbVie$111
- plus $540 from 14 others
What the payments were for
- Consulting fees$5,26010%
- Speaking & faculty fees$38,60871%
- Travel & lodging$5,89611%
- Food & beverage$4,6839%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 70 | $32,467 |
| Supernus Pharmaceuticals, Inc. | 163 | $12,967 |
| Corium, LLC | 17 | $8,090 |
| Lundbeck LLC | 16 | $154 |
| Sunovion Pharmaceuticals Inc. | 6 | $116 |
| AbbVie(2 entities) | 6 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Alkermes, Inc. | 4 | $70 |
| Shire North American Group Inc | 4 | $66 |
| Tris Pharma Inc | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $56 |
| Neurocrine Biosciences, Inc. | 3 | $36 |
| Avanir Pharmaceuticals, Inc. | 2 | $36 |
| Johnson & Johnson | 2 | $30 |
| Neos Therapeutics, LP | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Bausch Health US, LLC | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$23,712
- QELBREE$8,461
- Azstarys$7,797
- JORNAY PM$7,150
How this compares
$54,447 in reported general payments places this provider in the 95th percentile of 49 child & adolescent psychiatry providers in Wisconsin.
See all child & adolescent psychiatry providers in Wisconsin →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 17 | $24,764 |
| VyvanseLisdexamfetamine Dimesylate | 33 | $14,231 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,369 |
| Focalin XrDexmethylphenidate Hcl | 12 | $5,053 |
| Lisdexamfetamine Dimesylate | 20 | $3,712 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 39 | $2,305 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 56 | $1,958 |
| Divalproex Sodium ErDivalproex Sodium | 33 | $1,676 |
| Guanfacine Hcl ErGuanfacine Hcl | 46 | $1,458 |
| Olanzapine OdtOlanzapine | 19 | $1,381 |
| Aripiprazole | 11 | $1,324 |
| Oxcarbazepine | 19 | $1,323 |
| Olanzapine | 49 | $1,259 |
| Lamotrigine | 85 | $1,151 |
| Hydroxyzine Hcl | 33 | $1,036 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $111 | $24,76417 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $56 | $19,60044 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $18621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 49 child & adolescent psychiatry providers in Wisconsin.
Other child & adolescent psychiatry in Green Bay
- Sushma GunturuGreen Bay$49
- Lisa BrightJuneau$3K
- Jennifer Lahmannla Crosse$2K
- Cherie SgambatiMilwaukee$1K
- Kayla PopeWinnebago$1K
- Juan FernandezWausau$767
- Rathna MallelaJanesville$617
- Rosa KimMilwaukee$616
- Alexandra McMurrayMadison$537
- John KorgerOshkosh$485
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.